Plasma miRNA profile at COVID-19 onset predicts severity status and mortality-Reference-Cited by-同舟云学术

Plasma miRNA profile at COVID-19 onset predicts severity status and mortality

Published:2022-02-27 Issue:1 Volume:11 Page:676-688
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Fernández-Pato Asier¹²,Virseda-Berdices Ana¹^ORCID,Resino Salvador¹³^ORCID,Ryan Pablo³⁴⁵⁶,Martínez-González Oscar⁷,Pérez-García Felipe⁸⁹,Martin-Vicente María¹³^ORCID,Valle-Millares Daniel¹^ORCID,Brochado-Kith Oscar¹³^ORCID,Blancas Rafael⁷^ORCID,Martínez Amalia⁴,Ceballos Francisco C.¹^ORCID,Bartolome-Sánchez Sofía¹,Vidal-Alcántara Erick Joan¹,Alonso David¹⁰,Blanca-López Natalia¹¹,Ramirez Martinez-Acitores Ignacio⁷,Martin-Pedraza Laura⁴,Jiménez-Sousa María Ángeles¹³^ORCID,Fernández-Rodríguez Amanda¹³^ORCID

Affiliation:

1. Unit of Viral Infection and Immunity, National Center for Microbiology (CNM), Health Institute Carlos III (ISCIII), Madrid, Spain

2. Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

3. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain

4. Department of Infectious Diseases, Hospital Universitario Infanta Leonor, Madrid, Spain

5. School of Medicine, Complutense University of Madrid, Madrid, Spain

6. Gregorio Marañón Health Research Institute, Madrid, Spain

7. Critical Care Department, Hospital Universitario del Tajo, Aranjuez, Spain

8. Clinical Microbiology Department, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain

9. Department of Biomedicine and Biotechnology, Faculty of Medicine, University of Alcalá de Henares, Madrid, Spain

10. Internal Medicine Service, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain

11. Allergology Department, University Hospital Infanta Leonor, Madrid, Spain

Funder

Instituto de Salud Carlos III

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2038021

Reference60 articles.

1. Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands

2. Role of Host and Pathogen-Derived MicroRNAs in Immune Regulation During Infectious and Inflammatory Diseases

3. MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19

4. MicroRNAs: Mediators and Therapeutic Targets to Airway Hyper Reactivity After Respiratory Syncytial Virus Infection

5. A Computational Approach for Predicting Role of Human MicroRNAs in MERS-CoV Genome

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the development and clinical application of miRNAs in infectious diseases;Non-coding RNA Research;2025-02

2. The relationship between microRNAs and COVID-19 complications;Non-coding RNA Research;2025-02

3. An integrated bioinformatics approach reveals the potential role of microRNA-30b-5p and let-7a-5p during SARS CoV-2 spike-1 mediated neuroinflammation;International Journal of Biological Macromolecules;2024-10

4. Noncoding RNAs in the COVID-19 Saga: An Untold Story;Viral Immunology;2024-08-01

5. Maternal prenatal stress induces sex-dependent changes in tRNA fragment families and cholinergic pathways in newborns;2024-07-10